Residency, Emergency Medicine, McGaw Medical Center of Northwestern University, 2025
MD, Medicine, University of Miami Miller School of Medicine, 2021
PhD, Cellular and Molecular Pharmacology, University of Miami Miller School of Medicine, 2016
BS, Biology, University of Wisconsin-Madison, 2010
Research Interests
Stem cells
Sepsis
Endothelial function and vascular biology
Translational emergency medicine
Recent Publications
Premer, C., Hare, J. M., Yuan, S. Y., & Wilson, J. W. Mesenchymal stem/stromal cells as a therapeutic for sepsis: a review on where do we stand?Stem Cell Research & Therapy. 16(1) : 1-11, 2025.
Premer C, Schulman IH, Jackson JS. The Role of Mesenchymal Stem/Stromal Cells in the Acute Clinical Setting.The American Journal of Emergency Medicine. 46: 572-578, 2021.
Neves, AF, Camargo C, Premer C, Hare JM, Baumel BS, Pinto M. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.Experimental Neurology. 341, 2021.
Florea V, Rieger AC, Natasumeda M, Tompkins BA, Banerjee M, Schulman IH, Premer C, Valasaki K, Mantero A, Balkan W, Mitrani RD, Hare JH. The Impact of Sex on the Response to Intramyocardial Mesenchymal Stem Cell Administration in Patients with Non-Ischemic Dilated Cardiomyopathy.Cardiovascular Research. , 2020.
Ory J, Saltzman RG, Blauchman-Braun R, Dadoun S, DiFede DL, Premer C, Hurwitz B, Hare JM, Ramasamy R. Effect of Transendocardial Stem Cell Injection on Erectile Function in Men with Cardiomyopathy: Results from the TRIDENT, POSEIDON, and TAC-HFT Trials.Journal of Sexual Medicine. 17(4) : 695-701, 2020.
Premer C, Wanschel A, Porras V, Balkan W, Legendre-Hyldig T, Saltzman RG, Dong C, Schulman IH, Hare JM. Mesenchymal Stem Cells Improve Endothelial Function in Patients with Dilated Cardiomyopathy via an SDF-1α Mediated Mechanism.Frontiers in Physiology. 10: 1182, 2019.
Premer C, Kanelidis AJ, Hare JM, Schulman IH. Rethinking Endothelial Dysfunction as a Crucial Target in Fighting Heart Failure.Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 3(1) : 1-13, 2019.
Premer C, Schulman IH. Predictive Value of Circulating Progenitor Cells in Acute Coronary Syndrome: Implications for Treatment.Circulation Research. 122(11) : 1491-1493, 2018.
Thompkins B, DiFede DL, Khan A, Landin AM, Schulman IH, Pujol MV, Heldman AW, Miki R, Goldschmidt-Clermont PJ, Goldstein BJ, Mushtaq M Levis-Dusseau S, Byrnes JJ, Lowery M, Natsumeda M, Delgado C, Saltzman R, Video-Casiano M, Fonseca M, Golpanian S, Premer C, Medina A, Valasaki K, Florea V, Anderson E, El-Khorazaty J, Mendizabal A, Green G, Olivia AA, Hare JM. Allogeneic mesenchymal stem cells ameliorate aging frailty: A phase II randomized, double-blind, placebo-controlled clinical trial.The Journals of Gerontology. 72(11) : 1513-1522, 2017.
Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, Parker M, Demarkarian CR, Balkan W, Khan A, Hare JM. Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells.EBioMedicine. 2(5) : 467-475, 2015.
Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, Balkan W, Rodrigues CO, Schally AV, Hare JM. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells.Proceedings of the National Academy of Sciences. 110(8) : 2834-2839, 2013.
